Ignite Creation Date:
2024-05-05 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00433199
Status:
COMPLETED
Last Update Posted:
2015-01-27
First Post:
2007-02-08
Brief Title:
Testosterone Treatment for Hypogonadal Men
Sponsor:
Abbott
Organization:
Abbott
Study Overview
Official Title:
A Multi-Center Randomized Double-BlindPlacebo-Controlled Efficacy and Safety Study of Testosterone Gel 162 for the Treatment of Hypogonadal Men
Status:
COMPLETED
Status Verified Date:
2011-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Demonstrate efficacy and safety of Testosterone Gel 162 for the treatment of hypogonadal men
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None